Tata Consultancy Services, a leading global IT services, consulting and business solutions organization reported revenue growth of 4.2% QoQ CC in 4QFY21 (v/s our estimate of 3.4%), delivering its third consecutive quarter of broad based (over 4% QoQ) growth. It marginally improved its EBIT margin to 26.8% (+20bp QoQ/+170bp YoY). The same was below our estimate (27.2%) on ramp up of large deals. Deal wins in 4QFY21 stood at USD9.2 billion, the highest in its history, with a book-to-bill ratio of 1.5x. A good 4Q helped it report sales (USD)/EBIT/PAT growth of 0.6%/10%/0.4% in FY21, said Motilal Oswal Institutional Equities.
"Strong recovery from TCS, post the initial phases of the COVID-19 pandemic, indicates continued strength in the tech spending environment, along with its ability to capture outsized market share. The management commentary on enterprise demand, especially on Cloud, implies a positive outlook for peers as well. It also highlighted a robust pipeline, with a mix of small/mid-sized deals along with a few large ones, giving it confidence on client spends," it added.
TCS continued to positively surprise with its ability to manage attrition (7.2%, record low). Despite higher demand for talent in the market, the management feels it won’t face much pressure given its ability to train employees in Digital skills. TCS added 19.4k employees in 4QFY21, the highest in its history, the broking firm said.
Motilal Oswal expects TCS to be relatively better positioned (v/s the sector) to leverage the acceleration in large deals as clients increase spends on Cloud. "Backed by strong deal wins in FY21 and continued momentum in Cloud and Data, we expect the company to deliver ~16% USD growth CAGR over FY21-23E."
It reported an OCF/PAT of 100% and FCF/PAT of 87% on good working capital management. The total cost of the buyback (including expenses) was Rs 197.6 billion, resulting in 4QFY21 cash of Rs 504 billion (v/s Rs 654 billion in 3QFY21).
"We keep our EPS estimates unchanged. While we continue to be positive on the company, we remain Neutral given the elevated multiples, TP at Rs 3,250 . The stock currently trades ~25x FY23E EPS," it said.
In CC terms, revenue was up 4.2% QoQ, above estimate of 3.4%. On a YoY basis, revenue grew by 5.9% YoY CC.USD revenue was up 5% QoQ.
On a YoY basis, USD revenue was up 10% v/s their estimate of 8.8%. Overall TCV of deals won during 4QFY21 was at a record high of USD9.2b compared to USD8.9 billion in 4QFY20.
EBIT margin stood at 26.8% (v/s estimate of 27.2%), up 20bp QoQ and 180bp YoY.PAT grew 14.7% YoY to Rs 93 billion, 3% miss, on account of higher ETR at 25.9% v/s their estimate of 23.5%.
Growth was broad-based across verticals with BFSI (+7% QoQ, +13.3% YoY), Retail and CPG (+4% QoQ, -0.9% YoY), Life Sciences and Healthcare (+3.8% QoQ, +19.3% YoY), Manufacturing (+3.9% QoQ, +1.3% YoY), Technology and Services (+2.8% QoQ, +3.9% YoY), and Communications and Media (+1.8% QoQ, -4% YoY). 4QFY21 BFSI growth benefitted from scaling up of Postbank and Prudential captive deals.
On a full-year basis, Life Sciences and Healthcare (+17.1%), BFSI (+2.4%), and Technology and Services (+0.2%) grew, while the rest continued to be below prior year levels.Growth was dominated by Continental Europe (+8.5% QoQ CC). North America and the UK also saw healthy growth (3.9%/3.4% QoQ CC).
4QFY21 saw the highest net addition of employees at 19.4k QoQ at 488,649. This was further complimented by lowest ever LTM attrition of 7.2%.During 4QFY21, subcontracting cost increased by 80bp YoY. CFO/FCF was 100%/87% of PAT. Total cash and cash equivalents at the end of FY21 stood at Rs 504 billion.
Disclaimer: IRIS has taken due care and caution in compilation of data for its web site. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.
